The bovine serum albumin market is estimated to account for a value of USD 255 million in 2019 and is projected to grow at a CAGR of 3.0% from 2019, to reach a value of USD 304 million by 2025. The demand for bovine serum albumin has been growing in accordance with the rise in demand from the pharmaceutical industry. The other factors responsible for driving the global market are the changing consumer preferences for a protein-rich diet and high demand from the life sciences industry. The stable nature of bovine serum albumin as a protein standard makes it a preferred product in the pharmaceutical and diagnostic industries because of its highly pure nature and high solubility in water.
The feed industry segment, by end user, is estimated to witness the fastest growth in the bovine serum albumin market in 2019
The feed industry makes extensive use of food derived from animal blood for livestock production due to which the demand for BSA is growing in this sector. Livestock is one of the fastest-growing sectors within the agricultural industry, and it accounts for about 40% of the global value of agricultural production. The growing opportunities for bioactive ingredients in the feed industry are driving the growth of this segment.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=20219222
The technical-& diagnostic-grade, by grade, is estimated to account for the largest market share, by value, in 2019
This segment holds the largest market share in the bovine serum albumin market since it has a widespread application in the pharmaceutical and diagnostic industries. This grade is preferred in the life sciences industry due to its characteristic properties such as solubility and ease of filtration. This grade is also suitable for biotechnological applications such as immune detections, as a blocking agent and saturating agent. It is also used in cell culture applications.
The scope for the use of BSA as a dietary protein is opening new avenues for the application of BSA
It has been established that BSA is a dietary whey protein that has anti-obesity effects. The intake of BSA as a part of low-fat diets prevents weight gain. Since obesity is a growing problem, the manufacturers are looking at cost-effective solutions for the production of dietary supplements. The cost of raw material for the production of BSA is very low due to which it has the potential to be used as a dietary supplement.
The Asia Pacific region is projected to grow at the highest CAGR during the forecast period
The Asia Pacific region holds a range of opportunities for pharmaceutical firms and multinational drugmakers. In the Asia Pacific region, China is the largest market for pharmaceutical products. With the growing interest in health and welfare, the demand for pharmaceutical products is growing. This would help drive the growth of BSA in this region.
This report includes a study on the marketing and development strategies, along with a study on the product portfolios of the leading companies operating in the bovine serum albumin market. It includes the profiles of leading companies such as Thermo Fisher Scientific (US), Bio-Rad Laboratories, Inc (US), Merck KGAA (Germany), Itoham Yonekyu Holdings Inc (Japan), Proliant Biologicals (US), Kraeber & Co Gmbh (Germany), Rockland Immunochemicals Inc (US), Rocky mountain biologicals (US), BelHealth investment partners, LLC (US), Bio-Techne Corporation (US), Prospec-Tany Technogene Ltd (Israel), LGC Group (UK), Promega Corporation (US), Biological Industries (Israel), and Serion GmbH (Germany).
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Key questions addressed by the report:
Media ContactCompany Name: MarketsandMarketsContact Person: Mr. Shelly SinghEmail: Send EmailPhone: 1-888-600-6441Address:630 Dundee Road Suite 430 City: NorthbrookState: ILCountry: United StatesWebsite: https://www.marketsandmarkets.com/Market-Reports/bovine-serum-albumin-market-20219222.html
